These in vitro results have been confirmed with the finding of IGF-1R expression in clinical samples of Ewing's sarcoma and the demonstration that lower levels of IGF-1R expression correlate with a lower tumor proliferative rate and a better prognosis [46]. This evidence concerns the gene IGF1R and neoplasm.